News Articles


Prognostic impact of COX-2 in lung cancer

COX-2 stroma.png

In a study performed by scientists at Uppsala University, in collaboration with Gothenburg University and the Human Protein Atlas project, the expression of cyclooxygenase-2 (COX-2) was evaluated in patients with non-small cell lung cancer (NSCLC).

To clarify previous inconsistences concerning the prognostic impact of COX-2 expression in NSCLC, the association between COX-2 transcript levels (encoded by the gene PTGS2) and overall survival in nine publicly available gene expression microarray data sets were evaluated as well as the in situ protein expression of COX-2 in tumor and stromal cells in two independent NSCLC cohorts...Read more


Upcoming Events


Flow Cytometry & Imaging from single cell to the patient

November 14, 2018 - November 14, 2018

Dr Charlotte Stadler is Plenary Keynote Speaker presenting "An image based subcellular map of the human proteome" at the The 6th biennial Pharmaceutical Flow Cytometry and Imaging meeting, Stevenage, UK.
Overview

2018 ASCB | EMBO Meeting

December 8, 2018 - December 12, 2018

The Human Protein Atlas will be exhibiting at the 2018 ASCB EMBO meeting in San Diego. In booth number #624 you will meet the Cell Atlas team Emma Lundberg, Christian Gnann, Lovisa Ã…kesson and Peter Thul. They will also present four posters.
Preliminary programme